PTPRC and acute myeloid leukemia: This molecular mechanism is unique because CD45, which is mainly found within plasma-membrane lipid rafts on AML cells, is rapidly delocalized after treatment and therefore the effect of its phosphatase activity is subsequently profoundly affected.